Analysts expect Rhythm Pharmaceuticals, Inc. to report revenue of 99.86 M for Q4 26, against a range of 93.40 M to 106.32 M. The most recent reported quarter, Q3 26, came in at 92.13 M, a 0.8% beat against the 91.41 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 41.83 M | 32.70 M | 48.50 M | 51.30 M | 57.25 M | 60.11 M | 71.25 M | 92.13 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 39.17 M | 45.72 M | 44.28 M | 51.49 M | 57.03 M | 62.96 M | 67.49 M | 96.83 M | 106.32 M | 122.81 M | 154.04 M | 181.10 M | 192.61 M | 178.95 M | 221.61 M | 271.65 M | |||||||||
| Low Estimate | 34.20 M | 37.84 M | 39.70 M | 43.47 M | 50.89 M | 54.14 M | 63.07 M | 86.00 M | 93.40 M | 112.58 M | 126.71 M | 150.10 M | 159.31 M | 162.27 M | 194.63 M | 235.19 M | |||||||||
| Consensus Estimate | 36.69 M | 41.78 M | 41.99 M | 47.48 M | 53.96 M | 58.55 M | 65.28 M | 91.41 M | 99.86 M | 117.69 M | 140.37 M | 165.60 M | 175.96 M | 170.61 M | 208.12 M | 253.42 M |
Analysts expect Rhythm Pharmaceuticals, Inc. to report earnings per share of -1.89 for Q4 26, against a range of -2.04 to -1.74. The most recent reported quarter, Q3 26, came in at -0.61, a 9.0% beat against the -0.67 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.72 | -0.81 | -0.75 | -0.82 | -0.73 | -0.83 | -0.73 | -0.61 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.60 | -0.59 | -0.65 | -0.74 | -0.71 | -0.72 | -0.79 | -0.65 | -1.74 | -0.46 | -0.30 | -0.20 | -1.19 | 0.39 | 0.70 | 0.94 | |||||||||
| Low Estimate | -0.74 | -0.73 | -0.75 | -0.78 | -0.79 | -0.86 | -0.93 | -0.69 | -2.04 | -0.50 | -0.36 | -0.22 | -1.37 | 0.33 | 0.66 | 0.78 | |||||||||
| Consensus Estimate | -0.67 | -0.66 | -0.70 | -0.76 | -0.75 | -0.79 | -0.86 | -0.67 | -1.89 | -0.48 | -0.33 | -0.21 | -1.28 | 0.36 | 0.68 | 0.86 |
Pull Wall Street consensus for Rhythm Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RYTM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RYTM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RYTM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();